Delivery Order SPE2DB24D1021-SPE2DB25FEZFJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,011.68 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on September 3, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $9,737.35 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This non-set-aside contract employs firm fixed pricing under a delivery order contract type and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $4,906.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for 100 tablets of Onfil 10 mg. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $4,414.14. This competitive, non-set-aside award reflects a firm fixed-price delivery order placed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units) valued at $11,683.85 under a firm fixed-price contract type. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,638.32 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. The delivery order was awarded on August 25, 2025, and represents a single pharmaceutical transaction under AmerisourceBergen's broader federal contracting relationship. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Onfil 10 mg tablets (100-count) under a firm fixed-price contract with a ceiling value of $7,471.73. This non-set-aside award is classified as a delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical supply requirement within the...
- The Defense Logistics Agency awarded a delivery order valued at $1,884.13 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg, with delivery scheduled for completion by September 11, 2025. The contract was awarded on September 10, 2025, under a firm fixed-price arrangement with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,525.16 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Onfil 10 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance through July 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZFJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,422.19 to AmerisourceBergen Drug Corp for 100 tablets of Onfil 10 mg on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded contract utilizes firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA 19428. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, medical devices, vaccines, and healthcare commodities to support military healthcare programs globally. The contractor regularly fulfills such delivery orders for specialized medications across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/4/25 |